Medicare Enrolled
Dr. Adil Katabay, MD
Anesthesiology · Marion, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Katabay from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katabay?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Katabay
Dr. Adil Katabay is an anesthesiology specialist in Marion, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Katabay performed 7,436 Medicare services across 2,087 unique beneficiaries.
Between the years covered by Open Payments, Dr. Katabay received a total of $4,832 from 44 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Katabay is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in OH
$4,832 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,436
Medicare services
Top 0% in OH for anesthesiology
2,087
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~372 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, propofol, 10 mg | 2,011 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
963 | $55 | $130 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
701 | $236 | $400 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
699 | $12 | $100 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
504 | $0 | $2 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
502 | $0 | $0 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
270 | $85 | $150 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
210 | $32 | $226 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
162 | $32 | $215 |
| Injection, methylprednisolone acetate, 40 mg | 146 | $5 | $13 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
135 | $108 | $300 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
134 | $9 | $25 |
| Psychotherapy, 30 minutes A 30-minute session of psychotherapy involving talk therapy to address mental health concerns. |
123 | $46 | $85 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
90 | $86 | $400 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 84 | $45 | $218 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
74 | $8 | $25 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
72 | $306 | $1,150 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
68 | $168 | $505 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
67 | $181 | $611 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
67 | $95 | $315 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
66 | $79 | $110 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
59 | $158 | $551 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $70 | $195 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
34 | $165 | $650 |
| Destruction of peripheral nerve or branch | 30 | $128 | $370 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
29 | $13 | $141 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
22 | $258 | $1,160 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $186 | $676 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
21 | $97 | $339 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
19 | $171 | $575 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
16 | $41 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,832
Total received (2018-2024)
Avg $690/year across 7 years
Top 6% in OH for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,148 (85.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$684 (14.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,174
2023
$229
2022
$353
2021
$336
2020
$479
2019
$756
2018
$505
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lumenis BE inc
$1,215
PROTEGA PHARMACEUTIALS INC
$649
Collegium Pharmaceutical, Inc.
$127
Forte Bio-Pharma LLC
$51
Lundbeck LLC
$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Pacira Pharmaceuticals Incorporated
$24
Currax Pharmaceuticals LLC
$17
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 91.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lumenis BE inc
$1,215
Collegium Pharmaceutical, Inc.
$702
PROTEGA PHARMACEUTIALS INC
$649
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$372
BioDelivery Sciences International, Inc.
$204
Scilex Pharmaceuticals Inc.
$101
Medtronic USA, Inc.
$93
Teva Pharmaceuticals USA, Inc.
$91
Amgen Inc.
$89
Merz North America, Inc.
$75
AbbVie Inc.
$75
Novartis Pharmaceuticals Corporation
$74
PFIZER INC.
$65
Azurity Pharmaceuticals, Inc.
$63
ABBVIE INC.
$58
Supernus Pharmaceuticals, Inc.
$54
Abbott Laboratories
$54
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$52
Boston Scientific Corporation
$52
Forte Bio-Pharma LLC
$51
Lundbeck LLC
$50
Medline Industries, Inc.
$48
ARBOR PHARMACEUTICALS, INC.
$43
Daiichi Sankyo Inc.
$39
Kaleo, Inc.
$39
Hikma Pharmaceuticals USA
$35
Nevro Corp.
$33
Biohaven Pharmaceutical Holding Company Ltd.
$32
Currax Pharmaceuticals LLC
$32
SI-BONE, INC.
$30
Lilly USA, LLC
$27
Pacira Pharmaceuticals Incorporated
$24
Galderma Laboratories, L.P.
$24
US WorldMeds, LLC
$23
Arbor Pharmaceuticals, Inc.
$23
GRT US Holding, Inc.
$22
Allergan, Inc.
$19
SI-BONE, Inc.
$18
GENZYME CORPORATION
$18
BOSTON SCIENTIFIC CORPORATION
$16
Zyla Life Sciences, Inc.
$14
Horizon Therapeutics plc
$12
Pernix Therapeutics Holdings, Inc.
$11
FIDIA PHARMA USA INC.
$11
Top 3 companies account for 53.1% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AUBAGIO · Aimovig · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · CONTRAVE · EMGALITY · Evzio · Exparel · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · HORIZANT · Horizant · Hymovis · IFUSE IMPLANT · INTELLIS · Kloxxado · LUCEMYRA · LYRICA · Lamitrode SCS Leads · Lucemyra/Lofexidine · M22 · Morphabond ER · NALOCET · NURTEC ODT · Penta SCS Leads · Qutenza · RAYOS · RELISTOR · ROXYBOND · SPRIX · Senza Spinal Cord Stimulation System · TROKENDI XR · UBRELVY · VYEPTI · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · XtampzaER · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for anesthesiology in OH.
Geographic Context
Anesthesiologists within 10 mi
20
Per 100K population
30.7
County median income
$57,306
Nearest hospital
MARION GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Katabay is a clinical cardiology specialist, with above-average Medicare volume (top 0% in OH), with low-engagement industry engagement in the top 6% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Katabay experienced with injection, propofol, 10 mg?
Based on Medicare claims data, Dr. Katabay performed 2,011 injection, propofol, 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Katabay receive payments from pharmaceutical companies?
Yes. Dr. Katabay received a total of $4,832 from 44 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katabay's costs compare to other anesthesiologists in Marion?
Dr. Katabay's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katabay) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Marion
Browse anesthesiologists in Marion ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in OH
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in OH
Which OH anesthesiologists receive the most from drug and device companies.
By company
Lumenis BE inc Payments to Doctors
See all physicians who received payments from Lumenis BE inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
PROTEGA PHARMACEUTIALS INC Payments to Doctors
See all physicians who received payments from PROTEGA PHARMACEUTIALS INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology